MECHANISTIC HEALTH · EST. 2026

Tools built by scientists,
for everyday use.

We close the gap between peer-reviewed data and the people who need it most. Reference-grade for researchers, legible for everyone else — grounded in primary literature, structured for real-world use.

FIG · μ-OPIOID RECEPTOR (MOR) · PDB 5C1M
LIGAND · MORPHINE · Ki = 1.4 nM7TM · GPCR Class A
Substances Indexed
342+
EASY ACCESS · EASY TO READ
Primary
Literature Sourced
NPS
Coverage Included
01 · OUR MISSION

Rigour where it matters most.

Most research sits behind paywalls — and what isn't paywalled is often impenetrable. We do the parsing, cross-referencing, and stress-testing so that an institutional login isn't the price of admission.

Mechanistic Health was built on a simple conviction: the data exists, it's good, and the only thing standing between it and the people who need it is design.

Our tools are reference-grade. We don't round off the complexity — receptor subtype, CYP pathways, binding affinities, active metabolites — because precision is what makes the data useful. What we strip away is the friction.

We don't simplify science. We simplify access to it. — Mechanistic Health · Editorial principle
  • Harm reduction first — built for patients, clinicians and researchers in equal measure.
  • Mechanistic rigour over anecdotal classification.
  • Open access — free reference data, forever, no account required.
  • NPS coverage — designer benzos, nitazenes, and research chemicals indexed months ahead of mainstream tools.
  • Community peer review with primary-literature sourcing.
02 · THE MECHANISTIC SUITE

Built by scientists.
Accessible for everyone.

Each Mechanistic Health product is purpose-built for a specific pharmacological workflow — rigorous, open, and mechanistically grounded. Our flagship is live; the rest of the stack is in active development.

LIVE NOW

The Interaction Atlas 

The most comprehensive open-access drug-interaction reference ever built. 342+ substances · five risk tiers · receptor-level pharmacology · CYP pathways · DOI-linked primary citations. Free, forever.

FIG · CYP3A4 · METABOLIC CYCLE
SUBSTRATE → 1° METABOLITEHEME-Fe · O₂ · NADPH
FIG · DOSE–RESPONSE · μ-OPIOID
EC₅₀ · 38 nM · Emax 0.92FULL vs PARTIAL AGONIST
Coming next · the growing mechanistic stack
03 · DATA & PRIVACY

Your queries stay yours.

A privacy-first architecture. No accounts, no analytics fingerprinting, no data brokerage. The Atlas is a reference tool, not a funnel.

Local-first No data sold No account required Open methodology Anonymous by default
LAUNCHING SOON

Be the first to know.

One email per major release. Mechanistic API, mobile, Co-Pilot — when each goes live. Unsubscribe anytime.

No spam. One email when we launch. Unsubscribe anytime.
SOURCED FROM
PubMed / PubChem DrugBank EMCDDA openFDA · FAERS Primary Literature DOI Citations Peer Review